 prevalence
of ‚¨ç5%, screening has not been shown to reduce the risk of
stroke in a cost-effective manner and may be harmful.
Given these assumptions, screening of the general population is not indicated. This position is supported by
multiple professional organizations, including the National
Stroke Association,22 the Canadian Stroke Consortium23
and the U.S. Preventive Services Task Force.24 The American Stroke Association/AHA Stroke Council25 concluded
that highly selected patient populations may